Actively Recruiting
A Study to Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours
Led by Xijing Hospital · Updated on 2025-01-17
40
Participants Needed
1
Research Sites
145 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a study using an autocontrol approach, enrolling 40 patients with tumours of epithelial origin, who underwent 68Ga- MY6349 and 68Ga-PSMA/18F-FDG PET/CT imaging of patients with tumours of epithelial origin to compare the ability to diagnose, stage and monitor recurrence of tumours of epithelial origin using the pathological findings as the gold standard.
CONDITIONS
Official Title
A Study to Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Pathologically confirmed tumor with planned surgical resection or exploration (including primary or recurrent metastatic tumor)
- Expected survival longer than 3 months as judged by the doctor
- Voluntarily sign informed consent
- Willing and able to follow the study protocol
You will not qualify if you...
- Known allergy to 68Ga-MY6349, 68Ga-PSMA, 18F-FDG, or their excipients
- Unable to tolerate intravenous drug delivery methods (e.g., history of needle or blood sickness)
- Received anti-tumor therapy before the examination or neoadjuvant chemotherapy/targeted therapy after examination before surgery
- Pregnant or breastfeeding women
- Professionals needing long-term exposure to radioactive conditions
- Serious heart, kidney, lung, vascular, neurological, psychiatric diseases, immunodeficiency, hepatitis, or cirrhosis
- Participated in other interventional clinical trials within 1 month prior to screening
- Currently undergoing chemotherapy, immunotherapy, or molecular targeted therapy
- Other conditions making study participation unsuitable according to the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Nuclear Medicine,Xijing Hospital, Fourth Military Medical University, Xi'an, China
Xi'an, Shaanxi, China
Actively Recruiting
Research Team
Y
Ying Guo Ying Guo
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here